MAPT and Alzheimer disease: found that transferring fecal microbiota from healthy mice to AD mice improved the deposition of Aβ plaques, tau protein pathology, glial reactions, and cognitive impairment in the brains of AD mice.[139] Furthermore, the gut microbiota can influence the activity of intestinal macrophages and the expression of inflammatory monocyte‐related genes in the bloodstream.